KUNIZ 28 DAYS STARTER PACK (APREMILAST) 10mg 20mg 30mg TABLETS
KUNIZ TABLETS (APREMILAST) 28 days starter pack, kuniz 10mg, kuniz 20mg, kuniz 30mg Tablets.
Pouch 1: 1 blister of 4 tablets containing apremilast 10mg
Pouch 2: 1 blister of 4 tablets containing apremilest 20mg
Pouch 3: 4 blister of 47 tablets containing apremilest 30mg
(1 blister with 5 tablets and 3 blister with 14 tablets each
Branded by: Tabros Pharma

KUNIZ 28 DAYS STARTER PACK (APREMILAST) 10mg 20mg 30mg TABLETS: A Comprehensive Overview
Modern medicine continues to advance in treating various diseases and conditions. One such medical marvel is Kuniz, a medication in tablet form containing Apremilast, which has
shown immense promise in addressing certain autoimmune disorders. In this comprehensive article, we will delve into the composition, description, indications, usage, dosage, clinical pharmacology, and much more surrounding Kuniz tablets
Composition:
Kuniz tablets come in different strengths, each tailored to specific medical needs:
- Kuniz 10mg Tablets: Each filmcoated tablet contains 10mg of Apremilast
- Kuniz 20mg Tablets: For more robust requirements, these tablets contain 20mg of Apremilast
- Specific cases warrant the prescription of Kuniz 30mg Tablets, which contain the highest strength of 30mg Apremilast.
The active ingredient, Apremilast, is a phosphodiesterase 4 (PDE4) Inhibitor. Its chemical name is N(2-(4-ethoxy-3-methoxyphenyl)-1-(methylsulfonyl)ethyl)-2,3-dioxo-1,3-dihydro-1H-isoindol-4-yl acetamide, characterized by an empirical formula of C22H24N2O7S and a molecular weight of 460.5.
Indications and Usage:
Kuniz tablets have been approved for several medical
conditions:
- Kuniz offers hope and relief to adult patients with active psoriatic arthritis, treating this autoimmune joint disorder.
- Recommend it for the treatment of patients with moderate to severe plaque psoriasis who are eligible for phototherapy or systemic therapy
- Kuniz can provide much-needed relief from the painful condition of oral ulcers associated with Behcet's disease when treating adult patients.
Dosage and Administration:
The dosage of Kuniz tablets varies depending on the medical
condition being treated. Here are the recommended initial dosages and titration schedules for Psoriatic Arthritis and Psoriasis:
- Initial titration from Day 1 to Day 5, starting with 10mg, then 20mg, and eventually reaching 30mg twice daily from Day 6 onward
- When administering Apremilast tablets, ensure they remain intact and avoid crushing, splitting, or chewing them. These tablets can be taken irrespective of meals.
- Patients with severe renal impairment (creatinine clearance less than 30 mL per minute) should take a reduced dosage of 30mg once daily.
Clinical Pharmacology:
Apremilast, an oral small-molecule inhibitor of phosphodiesterase 4 (PDE4) specific for cyclic adenosine monophosphate (cAMP), is responsible for Kuniz's mechanism of action. At present, there isn't a complete understanding of how Apremilast precisely achieves its therapeutic effects in psoriatic arthritis and psoriasis.
In terms of pharmacokinetics, Apremilast exhibits good oral absorption with a bioavailability of approximately 73%. Peak plasma concentrations occur at a median time of around 2.5 hours, and co-administration with food does not affect its absorption. During the extensive metabolism of Apremilast in humans, researchers have identified several metabolites in plasma, urine, and feces.
The plasma clearance of Apremilast is about 10 L/hr, and it has a terminal elimination half-life of approximately 69 hours. Urine and feces excrete a significant portion of the drug.
Conclusion:
In conclusion, Kuniz tablets containing Apremilast offer hope and relief to patients battling psoriatic arthritis, psoriasis, and oral ulcers associated with Behcet's disease. The medication's well-defined dosage and clinical pharmacology make it a valuable addition to the arsenal of
treatments available to healthcare professionals in their quest to improve the lives of those affected by these autoimmune conditions. As medical science continues to progress, we can anticipate even more breakthroughs in the treatment of such disorders, offering a brighter future for patients worldwide
Usage and Benefits of Kuniz 28 Days Starter Pack (Apremilast)
Key Uses of Kuniz:
- Psoriatic Arthritis: Kuniz helps reduce pain and inflammation in the joints, improving mobility and overall quality of life for patients.
- Plaque Psoriasis: Kuniz is effective in managing moderate to severe plaque psoriasis, particularly for patients who are eligible for systemic therapies.
- Oral Ulcers (Behcetβs Disease): Kuniz provides relief from the painful oral ulcers caused by Behcetβs disease, reducing discomfort and promoting healing.
Benefits of Kuniz:
- Reduces Inflammation: Helps to alleviate inflammation and joint pain associated with psoriatic arthritis and psoriasis.
- Improves Skin Appearance: Provides significant relief for plaque psoriasis, reducing skin lesions and improving overall appearance.
- Soothes Oral Ulcers: Reduces the pain and discomfort caused by oral ulcers in Behcetβs disease, allowing for better comfort during daily activities.
- Targeted Action: The mechanism of action focuses on regulating immune responses to control inflammation and cell turnover.
How to Use Kuniz 28 Days Starter Pack (Apremilast) Tablets
To use Kuniz tablets, follow your doctorβs instructions carefully. The typical dosage for psoriatic arthritis and psoriasis includes:
- Day 1 to Day 5: Start with 10mg
- Day 2 to Day 5: Increase to 20mg
- From Day 6 onwards: Take 30mg twice daily
Swallow the tablets whole without crushing, splitting, or chewing them. You can take the medication with or without food.
For patients with severe renal impairment, the dosage is reduced to 30mg once daily. Always follow the prescribed dosage schedule to ensure optimal effectiveness.
Frequently Asked Questions (FAQ)
1. What is Kuniz and what conditions does it treat?
Kuniz is a medication containing Apremilast, a phosphodiesterase 4 (PDE4) inhibitor. It is used to treat active psoriatic arthritis, moderate to severe plaque psoriasis, and oral ulcers associated with Behcet's disease in adults.
2. How should I take Kuniz tablets?
Kuniz tablets should be taken as prescribed by your healthcare provider. The typical starting dose involves a titration from 10mg to 20mg and eventually reaching 30mg twice daily from Day 6 onwards. The tablets should be swallowed whole and not crushed, split, or chewed. They can be taken with or without food.
3. What are the common side effects of Kuniz?
Common side effects include diarrhea, nausea, headache, upper respiratory tract infections, and fatigue. However, side effects vary from person to person, so it's important to discuss any concerns with your healthcare provider.
4. Can Kuniz be taken with other medications?
Kuniz can be used alongside other medications, but you should always consult your doctor before combining it with any other treatments. It is important to avoid any drug interactions that may affect its efficacy or increase the risk of side effects.
5. Who should not use Kuniz?
Kuniz is not recommended for individuals with severe renal impairment (creatinine clearance less than 30 mL per minute) without dose adjustment. If you are pregnant, planning to become pregnant, or breastfeeding, consult your healthcare provider before starting Kuniz.
